# FDA recall D-0007-2016

> **Merck Sharp & Dohme, Wilson Facility** · Class II · drug recall initiated 2015-08-14.

## Product

Vytorin (ezetimibe and simvastatin) tablets, 10 mg/20 mg, each tablet contains 10 mg ezetimibe and 20 mg simvastatin, Rx Only, 1000 count Bottle, Manuf. For Merck Sharp & Dohme Corp, a subsidiary of Merck & Co., Inc., Whitehouse Station, NJ 08889, NDC 66582-0312-82.

## Reason for recall

Presence of Foreign Tablet/Capsule: Vytorin 10 mg/40 mg tablets were found in bottles of Vytorin 10 mg/20 mg tablets.

## Distribution

KY, MS and OH.

## Key facts

- **Recall number:** D-0007-2016
- **Recalling firm:** Merck Sharp & Dohme, Wilson Facility
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2015-08-14
- **Report date:** 2015-10-14
- **Termination date:** 2016-05-04

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Wilson, NC, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0007-2016

## Citation

> AI Analytics. FDA recall D-0007-2016. Retrieved 2026-05-28 from https://api.ai-analytics.org/recall/D-0007-2016. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*